Correction: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium
- Additional Document Info
- View All
This Article was originally published under Nature Research's License to Publish, but has now been made available under a CC BY-NC-ND license. The PDF and HTML versions of the Article have been modified accordingly.
has subject area